Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Roma

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Fondazione Policlinico Universitario Agostino Gemelli IRCCS, compiled from the ClinicalTrials.gov public registry.

575

Registered studies

383

Active

220

Recruiting now

112

Completed

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · NSCLC (Advanced Non-small Cell Lung Cancer) · Breast Cancer · Crohn's Disease

Recently updated registry entries

NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)
NCT07216703 — A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT03105102 — A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.